Boston Scientific Recalls All Implantable Defibrillators, Suspends Sales
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is recalling all lines of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators nationwide because the firm made manufacturing process changes without proper FDA approval
You may also be interested in...
HRS 2010: Subcutaneous ICD Generates Excitement, Controversy
In the years since the dawn of the ICD era in the 1980s, perhaps four expansions of the implantable cardioverter defibrillator have captured the imagination of electrophysiologists and signaled unqualified success for the major manufacturers of these life-saving devices. Now, a new generation of ICD--the S-ICD or totally subcutaneous ICD--has the potential to join those sophisticated devices as the next truly evolutionary development in the field. Interest in the S-ICD picked up steam this spring in Denver at the 31st annual scientific sessions of the Heart Rhythm Society, where researchers presented the latest clinical results with the device.
HRS 2010: Subcutaneous ICD Generates Excitement, Controversy
In the years since the dawn of the ICD era in the 1980s, perhaps four expansions of the implantable cardioverter defibrillator have captured the imagination of electrophysiologists and signaled unqualified success for the major manufacturers of these life-saving devices. Now, a new generation of ICD--the S-ICD or totally subcutaneous ICD--has the potential to join those sophisticated devices as the next truly evolutionary development in the field. Interest in the S-ICD picked up steam this spring in Denver at the 31st annual scientific sessions of the Heart Rhythm Society, where researchers presented the latest clinical results with the device.
St. Jude Beats Estimates, With 'Small Impact' From Boston Sci Absence
St. Jude Medical's better-than-expected first quarter benefited from Boston Scientific's month-long hiatus from the U.S. implantable defibrillator market, but that was not the pivotal factor, according to the company